In particular, 18F-THK5351 has limited utility as a sole biomarker of AD-related tauopathy due to its binding to monoamine oxidase-B (MAO-B; Ng et al., 2017; Harada et al., 2018). This evidence concerns the gene MAOB and tauopathy.